POTELIGEO
Generic: mogamulizumab-kpkc
- Manufacturer
- Kyowa Kirin
- NDC
- 42747-761
- RxCUI
- 2054081
- Route
- INTRAVENOUS
- ICD-10 indication
- C84.00
Affordability Check
How much will you actually pay for POTELIGEO?
In 30 seconds, see every legitimate way to afford POTELIGEO — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.
About POTELIGEO
What is this medication? POTELIGEO is a prescription medication used to treat adults with mycosis fungoides or Sezary syndrome. These are rare types of non-Hodgkin lymphoma that primarily affect the skin but can also involve the blood, lymph nodes, and internal organs. The treatment is typically reserved for patients who have already tried at least one other systemic therapy that was not successful or if their cancer has come back.
As a monoclonal antibody, this medication works by targeting a specific protein called CC chemokine receptor type 4 that is found on the surface of certain cancer cells. By binding to these proteins, the drug helps the immune system identify and destroy the malignant cells. It is administered as an infusion into a vein by a healthcare provider, usually following a specific dosing schedule based on the patient's individual treatment plan.
Copay & patient assistance
- Patient Copay Amount: Not Publicly Available
- Maximum Annual Benefit Limit: Not Publicly Available
- Core Eligibility Restrictions: Must be a U.S. resident with an active primary commercial insurance plan. Patients with government insurance (such as Medicare, Medicaid, and TRICARE) are not eligible for copay assistance. For the Patient Assistance Program (uninsured), patients must be U.S. residents with no active medical or pharmacy benefit insurance and meet specific income criteria.
- RxBIN, PCN, and Group numbers: Not Publicly Available
External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.
Compare pricing elsewhere
RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.
Cost Plus Drug Company
Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for mogamulizumab-kpkc.
Browse Cost Plus medications →
GoodRx
Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.
Lookup POTELIGEO →
NeedyMeds
Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.
Search for mogamulizumab-kpkc →
RxAssist
PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.
Search PAPs →
We deep-link because transparency helps patients. None of these partners pay RxCopays.
Conditions we've indexed resources for
Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.
Prior authorization & coverage
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
Related drugs
Physician EZ Use Joint Tunnel and Trigger Kit
Treats same condition · AMMONIA, LIDOCAINE HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, POVIDONE-IODINE
Prednisolone Sodium Phosphate Oral Solution
Treats same condition · prednisoLONE sodium phosphate
JYLAMVO
Treats same condition · Methotrexate
Marbeta L Kit
Treats same condition · Betamethasone Sodium Phosphate, Betamethasone Acetate, Lidocaine Hydrochloride, Bupivacaine Hydrochloride, Povidine Iodine, Isopropyl Alcohol
ADCETRIS
Treats same condition · brentuximab vedotin
Vinblastine Sulfate
Treats same condition · VINBLASTINE SULFATE
Prednisone delayed release
Treats same condition · Prednisone
Dyural 80-LM
Treats same condition · Methylprednisolone Acetate, Lidocaine Hydrochloride, Bupivacaine Hydrochloride, Povidine Iodine, Isopropyl Alcohol
Orapred ODT
Treats same condition · prednisolone sodium phosphate
BL-C Kit
Treats same condition · Betamethasone Sodium Phosphate, Betamethasone Acetate, Lidocaine, Iodixanol, Povidine Iodine
How this page is sourced
- Drug identity verified against openFDA NDC Directory.
- Label text (when shown) originates from NLM DailyMed.
- Copay and assistance URLs verified periodically; if you hit a broken link, tell us.
Rare-disease navigation (specialists, trials, patient communities)
POTELIGEO treats a rare condition. For in-depth disease pages on our sister site:
UniteRare.org is our sister site for rare-disease navigation — same editorial team, same accuracy standards.